UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2015 UpToDate®

Management of new onset atrial fibrillation

Authors
Robert Phang, MD, FACC, FHRS
Brian Olshansky, MD
Section Editors
Peter J Zimetbaum, MD
Hugh Calkins, MD
James Hoekstra, MD
Deputy Editor
Gordon M Saperia, MD, FACC

INTRODUCTION

This topic will discuss the initial management of patients who are given a diagnosis of atrial fibrillation (AF). The majority of such patients can receive early care in a practitioner’s office, an urgent care center, or an emergency department.

The diagnosis of new onset AF is usually made with an electrocardiogram or other electrocardiographic rhythm recording device (eg, ambulatory or inpatient monitoring). (See "Overview of atrial fibrillation", section on 'Electrocardiogram'.)

This topic will address the following management decisions, which need to be made soon after a patient presents with new onset AF (algorithm 1):

When and how should rate control be carried out? (See 'Rate control' below.)

Is cardioversion indicated and if so should it be urgent? (See 'Urgent management' below and 'Restoration of sinus rhythm' below.)

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2015. | This topic last updated: Jan 5, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2015 UpToDate, Inc.
References
Top
  1. Walkey AJ, Benjamin EJ, Lubitz SA. New-onset atrial fibrillation during hospitalization. J Am Coll Cardiol 2014; 64:2432.
  2. Garratt C, Antoniou A, Ward D, Camm AJ. Misuse of verapamil in pre-excited atrial fibrillation. Lancet 1989; 1:367.
  3. Fujimura O, Smith BA, Kuo CS. Effect of verapamil on an accessory pathway manifesting as "fatigue phenomenon" in Wolff-Parkinson-White syndrome. Chest 1993; 104:305.
  4. Weigner MJ, Caulfield TA, Danias PG, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 1997; 126:615.
  5. Dell'Orfano JT, Kramer RK, Naccarelli GV. Cost-effective strategies in the acute management of atrial fibrillation. Curr Opin Cardiol 2000; 15:23.
  6. Kim MH, Conlon B, Ebinger M, et al. Clinical outcomes and costs associated with a first episode of uncomplicated atrial fibrillation presenting to the emergency room. Am J Cardiol 2001; 88:A7, 74.
  7. Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999; 33:379.
  8. Domanovits H, Schillinger M, Thoennissen J, et al. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion. Resuscitation 2000; 45:181.
  9. Danias PG, Caulfield TA, Weigner MJ, et al. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998; 31:588.
  10. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385.
  11. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64:e1.